Tablets & Capsules


Issue link:

Contents of this Issue


Page 9 of 55

8 March 2018 Tablets & Capsules established Atmo Biosciences to commercialize the capsules. A study on the trials was published in the first volume of Nature Electronics. Star-shaped capsule delivers weeklong HIV treatment CAMBRIDGE, MA—Researchers at MIT and Brigham and Women's Hospital have developed a capsule that slowly releases three different HIV treatments over a weeklong period. This once-weekly dose could improve patient adherence and prevent infection if taken by individuals at risk of HIV exposure. The star-shaped capsule has six arms that can be loaded with drugs, folded inward, and coated. After the capsule is swallowed, the arms unfold, gradually release the drug, and eventually disintegrate into smaller components that can pass through the digestive tract. Researchers are adapting the capsule to treat other diseases as well as designing capsules that can remain in the body for longer periods. The study appeared the January issue of Nature Communications. colonoscopies. The capsule measures hydrogen, carbon dioxide, and oxygen in real time and sends the data to a mobile phone. Using this tool, doctors can diagnose many gut conditions from food nutrient malabsorption to colon cancer. The capsule also offers a more effective way to measure stomach microbiome activity, an important indicator of gut health. Because of the product's success in human trials, researchers have partnered with Planet Innovation, Box Hill, Australia, and research news Electronic capsule offers non- invasive alternative to colonoscopy M E L B O U R N E , A u s t r a l i a — Researchers at RMIT University have created an ingestible capsule that detects and measures gut gases, providing a non-invasive alternative to markets Pharmaceutical rigid packaging market to reach $250 billion ELMHURST, IL—The increasing d e m a n d f o r c h i l d - p r o o f b l i s t e r packaging will encourage pharma- ceutical packagers to develop new kinds of blister packs, which in turn will stimulate growth in the global pharmaceutical rigid packaging market, according to a report by Technavio. This market is forecast to reach $250 billion by the end of 2018 and grow at a compound annual rate of 7 percent through 2022. The study identifies Amcor, Bemis Company, Berry Global, Garresheimer, and WestRock as key market players. Generics to drive growth in HPAPI market NORTHBROOK, IL—The global high-potency active pharmaceutical ingredient (HPAPI) market is forecast to grow at a compound annual rate of 8.5 percent and be worth 24.09 billion by 2021, according to a study by

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0318